This event is now closed, information is displayed here for information only.
The 2017 ‘Frontiers of Oncology: Haematology’ meeting will be announced in January 2017
but you can pre-register HERE to be advised when the programme is released


A one day meeting held on
Tuesday 18th October 2016
The Royal College of Physicians, London, UK


Professor Charles Swanton
Professor Charles Swanton
Chair in Personalised Cancer Medicine
UCL Cancer Institute
Professor Siow-Ming LeeProfessor Siow-Ming Lee
Professor of Medical Oncology
University College London

08.00 Registration & Coffee
09.00 Welcome / setting the scene: the Chairmen
SESSION 1: Biological, Systemic and Radiation Therapies (session duration: 1hr 25mins)
09.05 Introduction from session Chair: Professor Siow-Ming Lee
09.10 Advances in Biological Therapies
Professor Fiona Blackhall
Professor of Thoracic Oncology, Manchester University and Honorary Consultant Medical Oncologist, The Christie, Manchester, UK
09.30 Recent Advances in Lung Cancer Management
Professor Siow-Ming Lee
Professor of Medical Oncology, University College London; Consultant Medical Oncologist, UCL Hospitals, London, UK
09.50 New advances Radiation Therapy
Professor Corinne Faivre-Finn
Professor of Thoracic Radiation Oncology & Honorary consultant clinical oncologist, University of Manchester, UK
10.10 Q&A
10.25 Summary
10.30 Break
SESSION 2: Keynote & Biology (session duration: 1hr 30mins)
11.00 Introduction from session Chair: Professor Charles Swanton
11.05 One billion deaths from tobacco this century – not just lung cancer
Sir Richard Peto
Professor of Medical Statistics and Epidemiology at the University of Oxford, UK
11.35 Q&A
11.45 Immune checkpoint blockade for lung cancer
Dr Sergio Quezada
Head of the Immune Regulation and Tumor Immunotherapy Group, UCL Cancer Institute, London, UK
12.15 Q&A
12.25 Summary
12.30 Lunch
SESSION 3: Early Diagnosis (session duration: 1hr 45mins)
13.30 Introduction from session Chair: Professor Charles Swanton
13.35 Biomarkers
Professor Caroline Dive
Professor of Pharmacology at the University of Manchester, Manchester, UK
13.55 The extent and clinical implications of intra-tumour heterogeneity in lung cancer
Dr Nicholas McGranahan
UCL/The Crick Institute, London, UK
14.15 Managing clonal evolution and intra-tumour heterogeneity in lung cancers
Professor Charles Swanton
Medical Research Council and Cancer Research UK Senior Clinical Research Fellow & Group Leader, the Translational Cancer Therapeutics Laboratory, CR-UK London Research Institute, UK
14.35 Do we have sufficient evidence to implement lung cancer CT screening?
Professor Samuel Janes
Professor of Respiratory Medicine, Centre for Respiratory Research, UCL, London, UK
14.55 Q&A 15mins
15.10 Summary
15.15 Break
SESSION 4: Early Diagnosis & Surgery (session duration: 1hr 15mins)
15.45 Introduction from session Chair: Professor Samuel Janes
15.50 Diagnosing lung and chest conditions using Endobronchial Ultrasound (EBUS)
Dr Neal Navani
Consultant in Thoracic Medicine, lead of the regional Endobronchial Ultrasound (EBUS) service at UCLH, London, UK
16.15 State-of-the-Art Robotic Surgery in Lung Cancer
Mr David Lawrence
Consultant Cardiothoracic Surgeon UCLH NHS Trust, London, UK
16.40 Q&A 10mins
16.50 Summary & Close

The meeting costs will be underwritten by Pharmaceutical Industry sponsors and the event is free of charge for healthcare professionals to attend. Places are strictly limited by room capacity.

This meeting is organised by:

New UCL Logo2 800


and endorsed and supported by:




The Frontiers of Oncology 2019 meetings are supported by the Pharmaceutical Industry.
As support agreements are reached, disclosure of the supporters is listed here.